Prostaglandin E2dependent migration of human brain endothelial cells is mediated through Rho-Kinase-II

Prostaglandin E2dependent migration of human brain endothelial cells is mediated through Rho-Kinase-II

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Gausal Azam Khan, Arjun Ghosh
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12185010/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prostaglandin E2 dependent migration of human brain endothelial cells is mediated through Rho-Kinase-II.
by: Gausal Azam Khan, et al.
Published: (2025-01-01)

Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
by: Naoki Okumura, et al.
Published: (2017-01-01)

Bortezomib induces Rho-dependent hyperpermeability of endothelial cells synergistically with inflammatory mediators
by: Shunichi Nishima, et al.
Published: (2024-12-01)

Rho-Kinase Inhibitors in the Management of Fuchs Endothelial Corneal Dystrophy: A Review
by: Anđela Jukić, et al.
Published: (2025-04-01)

Rho Kinase in Eye Disease
by: Naoki Okumura, et al.
Published: (2017-01-01)

Peripheral Rho-associated protein kinase activation mediates acupuncture analgesia
by: Ji-Yeun Park, et al.
Published: (2024-09-01)

Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin.
by: Be'eri Niego, et al.
Published: (2017-01-01)

Modified Saengmaeksan, an herbal formula containing six herbs, improves hypertension through RhoA/Rho kinase-mediated vasorelaxation
by: Young Mi Seok, et al.
Published: (2025-12-01)

Effect of alpha-linolenic acid on aminoglycoside nephrotoxicity and RhoA/Rho-kinase pathway in kidney
by: Percin Pazarci, et al.
Published: (2024-10-01)

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor
by: Jiannong Dai, et al.
Published: (2024-12-01)

Neural crest cell survival is dependent on Rho kinase and is required for development of the mid face in mouse embryos.
by: Helen M Phillips, et al.
Published: (2012-01-01)

Prostaglandins in Cancer Cell Adhesion, Migration, and Invasion
by: David G. Menter, et al.
Published: (2012-01-01)

Latest Update in Glaucoma: The first approvals for Rho Kinase inhibitors
by: Jatinder Bali, et al.
Published: (2020-04-01)

Ponatinib and other clinically approved inhibitors of Src and Rho-A kinases abrogate dengue virus serotype 2- induced endothelial permeability
by: Srishti Rajkumar Mishra, et al.
Published: (2025-12-01)

Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
by: Chatzimichail E, et al.
Published: (2025-04-01)

Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01)

Association of Rho-kinase Gene Polymorphisms with Respiratory Distress Syndrome in Preterm Neonates
by: Gül Kaya, et al.
Published: (2017-02-01)

Dual Effects of Rho-Kinase Inhibitors on a Rat Model of Inflammatory Pain
by: Patricia Paiva-Lima, et al.
Published: (2014-01-01)

Obscurin Rho GEF domains are phosphorylated by MST-family kinases but do not exhibit nucleotide exchange factor activity towards Rho GTPases in vitro.
by: Daniel Koch, et al.
Published: (2023-01-01)

Chemerin Enhances Migration and Invasion of OC Cells via CMKLR1/RhoA/ROCK-Mediated EMT
by: Xiaojing Sun, et al.
Published: (2024-01-01)

Quantitative Structure-Activity Relationship Studies for Potential Rho-Associated Protein Kinase Inhibitors
by: Giovanna Cardoso Gajo, et al.
Published: (2016-01-01)

Interleukin and prostaglandin status of patients with shingles depending on the severity of the disease
by: O. M. Novytskyi, et al.
Published: (2020-08-01)

Assessing clinical and morphological features of megalotrichosis induced by Tyrosine kinase inhibitors versus Prostaglandins analogues.
by: Rotem Gershon, et al.
Published: (2024-01-01)

Descemet Endothelial Thickness Comparison Trial 1 (DETECT 1): outcome masked, placebo-controlled trial comparing two types of corneal transplant surgeries and effect of rho kinase inhibitors on endothelial cell loss protocol
by: Thomas M Lietman, et al.
Published: (2024-04-01)

Increase in the constrictor effects of Rho-kinase in skeletal muscle and coronary arteries of rats with chronic hypothyroidism
by: D. K. Gaynullina, et al.
Published: (2018-12-01)

Integrin-specific control of focal adhesion kinase and RhoA regulates membrane protrusion and invasion.
by: Patricia Costa, et al.
Published: (2013-01-01)

Managing pseudophakic bullous keratopathy with a topical rho kinase inhibitor: a case series
by: Nir Erdinest, et al.
Published: (2025-05-01)

A Protein Kinase Cε/Protein Kinase D3 Signalling Axis Modulates RhoA Activity During Cytokinesis
by: Ursula Braun, et al.
Published: (2025-02-01)

Brain Levels of Prostaglandins, Endocannabinoids, and Related Lipids Are Affected by Mating Strategies
by: Jordyn M. Stuart, et al.
Published: (2013-01-01)

Therapeutic Potential of Rho Kinase Inhibitors in Corneal Disease: A Systematic Review of Preclinical and Clinical Studies
by: Laura Andreea Ghenciu, et al.
Published: (2025-06-01)

Inhibition of Rho Kinase Induces Antioxidative Molecules and Suppresses Reactive Oxidative Species in Trabecular Meshwork Cells
by: Tomokazu Fujimoto, et al.
Published: (2017-01-01)

Development of Poly Lactic/Glycolic Acid (PLGA) Microspheres for Controlled Release of Rho-Associated Kinase Inhibitor
by: Sho Koda, et al.
Published: (2017-01-01)

Hepatocyte Rho-associated kinase signaling is required for mice to survive experimental porphyria-associated liver injury
by: Jessica M. Herrera, et al.
Published: (2025-02-01)

NEK2 Phosphorylates RhoGDI1 to Promote Cell Proliferation, Migration and Invasion Through the Activation of RhoA and Rac1 in Colon Cancer Cells
by: Jeewon Lim, et al.
Published: (2024-12-01)

Extracellular osmolarity regulates osteoblast migration through the TRPV4-Rho/ROCK signaling
by: Yijie Li, et al.
Published: (2025-03-01)

Activation State-Dependent Substrate Gating in Ca2+/Calmodulin-Dependent Protein Kinase II
by: D. E. Johnson, et al.
Published: (2017-01-01)

Inhibition of Contractility of Isolated Caprine Detrusor by the Rho Kinase Inhibitor Fasudil and Reversal by the Guanylyl Cyclase Inhibitor ODQ
by: Niranjana Jeba Jeeviha, MD, et al.
Published: (2025-01-01)

Cigarette Smoke Exposure Leads to Organic and Mineral Bone Component Changes: The Importance of Rho Kinase Function in These Events
by: Alex Ferreira da Silva, et al.
Published: (2025-03-01)

Janus Kinase 2/Signal Transducer and Activator of Transcription 3/Cyclooxygenase 2 Signaling Pathway Mediates the Effect of Central Angiotensin II on the Elevation of Rostral Ventrolateral Medulla Prostaglandin E2‐Induced Oxidative Stress in Hypertension
by: Jie‐Fu Fan, et al.
Published: (2025-01-01)

Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer
by: Razia Rahman, et al.
Published: (2025-05-01)